Biden's Rationing of Alzheimer's Treatments is Just the Beginning

By Saul Anuzis

The Biden administration just barred most seniors from accessing new treatments for Alzheimer's Disease.

The decision doesn't merely cut off a potential lifeline for the roughly one in 10 Medicare enrollees afflicted with this deadly dementia. It also sets a precedent that should terrify tens of millions of seniors -- and their loved ones -- battling other diseases, from cancer to diabetes.

The Centers for Medicare & Medicaid Services decided to only cover the new Alzheimer's treatment, aducanumab -- which is approved by the FDA -- for patients enrolled in its own clinical trials.

This move is unprecedented. The FDA is staffed with scientists and other medical experts who spend months reviewing reams of clinical data to determine whether experimental medicines are safe and effective enough to warrant approval. New medicines are backed by some of the strongest research in health care. If FDA scientists and clinicians conclude that a treatment's benefits outweigh its risks and should be available to American patients, then it should be, full stop.

CMS officials are tasked with administering the federal government's largest insurance programs. The agency's staffers are not qualified to evaluate a drug's efficacy and safety -- that's the FDA's job.

But this time, CMS decided to second-guess the experts at the FDA.

Bureaucrats responsible for administering the $400 billion Medicare program supposedly took issue with the FDA's rationale for approving the drug on an "accelerated" basis, and claim they want more evidence of its effectiveness before covering it for up to 1.5 million Medicare enrollees with early-stage Alzheimer's who would otherwise qualify to take it, based on the drug label that the FDA approved. By the time CMS is done, none of those enrollees will still be in the "early-stage" category.

This sets a dangerous precedent. If CMS realizes it can use this type of procedure to unilaterally ration treatments, it's unlikely to stop at Alzheimer's drugs. It could use the same excuses to restrict seniors' access to all sorts of breakthrough medicines for cancer, multiple sclerosis, and dozens of other common, hard-to-treat diseases.

This rationing isn't merely cold-hearted. It's also financially short-sighted.

In 2020, Medicare and Medicaid's direct expenditures on Alzheimer's care totaled $206 billion. Those costs will exceed $750 billion by 2050, unless scientists develop treatments that can significantly slow the disease. New treatments that delay the progression of Alzheimer's could save $220 billion over 5 years, with 60% of those savings going towards Medicare and Medicaid.

Yet research companies will be reluctant to invest in such treatments if CMS refuses to cover the medicines.

Every new treatment is an investment in our future. New medicines drive down long-term costs for our healthcare system and patients. And beyond the financial savings, new treatments could cut the number of people suffering from Alzheimer's by 42% by 2050. Investing and approving groundbreaking medical treatment now will mean money and lives saved down the line.

None of these potential victories against Alzheimer's, cancer, ALS, multiple sclerosis, or any other hard to treat diseases will come to fruition if CMS continues to veer well outside its lane, and second guesses the authority and expertise of the FDA. Seniors and taxpayers alike will be harmed by CMS's short-sighted rationing.

Saul Anuzis is president of 60 Plus, the American Association of Senior Citizens. This piece originally appeared in the Detroit News.

More Resources

$errorCode = 9
xml_error_string() = Invalid character
xml_get_current_line_number() = 380
xml_get_current_column_number() = 23
xml_get_current_byte_index() = 39051
Custom Search

More Alzheimer's Articles:

Related Articles

The Symptoms of Alzheimer's Disease

Alzheimer's Disease is a disease that impairs the brain and causes memory loss, particularly in the elderly. What in effect happens is that nerve cells in the brain die manifesting itself with symptoms of memory loss. Nerve cells are crucial to the process of recall. Although the disease develops slowly it will eventually lead to death. Alzheimer's disease is the 9th most common cause of death for those who are 65 years old or more. It is worth noting that the average time from diagnosis till death is approximately 8 years, although some suffers have lived for 20 years, before the disease leads to death.

Alzheimer's Disease and Music Therapy

Activities for Alzheimers patients will often depend on the stages of Alzheimer's disease that the person is at. Alzheimer disease and music therapy are now used in many cases with some amazing results. One of the most remarkable things about this sad disease is the joy and comfort that Alzheimer's disease and music therapy can bring, my late Gran suffered from Alzheimer's in her latter years and my Dad used to always play some old songs on a Wednesday night.

New Brain Health Roadmap Announced

On June 10th something wonderful happened, and the media hasn't paid much attention yet. On that day, the National Public Health Road Map to Maintaining Cognitive Health was released by the CDC and the Alzheimer's Association. IN this article, I want to first share with you the 10 top actions proposed by this report, and then provide a quick glossary to explain the key words that you will hear more and more when discussing brain health.

Caring For Parents With Alzheimer's Disease

Alzheimer's disease directly affects about four million people in the United States, though it affects many more of us indirectly. While we may not be suffering from the disease personally, many of us are in a position where it has become necessary to care for someone with Alzheimer's.

Therapy Pets Prove Soothing to People With Alzheimer's

The recent win of Diamond Jim, an English Springer spaniel, at the Westminster Kennel Club's annual top dog competition in New York City brought attention to an increased calling for select pets across the country; serving as therapy dogs for people with Alzheimer's and other disabling ailments. The dog, commonly called James, is retiring from the show world to live the life of a therapy dog. James and his human partner have already worked with people with Alzheimer's, proving a soothing presence in nursing homes where they visit.

Helpful and Fun Activities For Patients With Alzhemier's Disease

If you are caring for someone with Alzheimer's Disease or even someone living with this disease there are some easy and fun activities that you can do to help ward off the effects of Alzheimer's disease. These activities will help to keep your brain active, flexible and alert.

Alzheimers Info To Make Your Life Easier

Probably one of the most difficult things you'll every have to do, is care for someone with Alzheimers. The reality that the person with Alzheimers is likely very close to you, only makes the task more challenging. Being armed with as much Alzheimers info as possible, and knowing where you can turn to if you need more help or information can make a world of difference. Being someone who cares for another human being puts you into a category with a high degree of burnout. It can be a stressful, thankless job. You need to stack the odds in your favor as much as possible.

Heavy Metal Anchors Alzheimer's in Your Brain

Heavy metals and aluminum are in every part of our environment and food. These elements are deadly and you will benefit if you are aware of what they do where they come from.

Signs of Alzheimer's Disease

As most of us grow older, it's normal to fear the onset of Alzheimer's disease. Millions of people around the globe suffer from its affects daily and since it is a disease that is so closely associated with growing older, it's natural to think that it is going to happen to you, especially if you have a family history of Alzheimer's in your family. There are signs of Alzheimer's disease that you can watch out for.

Do Elevated Homocysteine Levels Increase Risk For Alzheimer's Disease?

A natural amino acid called homosysteine has recently been linked to several age related diseases. Some researchers believe it may also be linked to the onset of Alzheimer's Disease.